| July - December 2018 |
|
PERCENT (%) RESISTANCE
TO SELECTED ANTIBIOTICS BY HOSPITAL |
| |
| Acinetobacter baumanii |
| |
Amikacin (all clinical specimens) |
| |
Ceftazidime (all clinical specimens) |
| |
Ciprofloxacin (all clinical specimens) |
| |
Ampicillin/Sulbactam (all clinical specimens) |
| |
Cefepime (all clinical specimens) |
| |
Imipenem (all clinical specimens) |
| |
Piperacillin/Tazobactam (all clinical specimens) |
| |
Multiresistance (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| Pseudomonas aeruginosa |
| |
Amikacin (all clinical specimens) |
| |
Ceftazidime (all clinical specimens) |
| |
Ciprofloxacin (all clinical specimens) |
| |
Imipenem (all clinical specimens) |
| |
Piperacillin/Tazobactam (all clinical specimens) |
| |
Multiresistance (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| Enterobacter spp |
| |
Tobramycin (all clinical specimens) |
| |
Ceftazidime (all clinical specimens) |
| |
Ciprofloxacin (all clinical specimens) |
| |
Imipenem (all clinical specimens) |
| |
Cefepime (all clinical specimens) |
| |
Piperacillin/Tazobactam (all clinical specimens) |
| |
Multiresistance (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| S. aureus |
| |
MRSA (all clinical specimens) |
| |
Methicillin and Gentamicin (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| Klebsiella pneumoniae |
| |
Ceftazidime (all clinical specimens) |
| |
Ciprofloxacin (all clinical specimens) |
| |
Imipenem (all clinical specimens) |
| |
Cefepime (all clinical specimens) |
| |
Cefoxitine (all clinical specimens) |
| |
Tobramycin (all clinical specimens) |
|
Piperacillin/Tazobactam
(all clinical specimens) |
| |
Multiresistance (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| Proteus mirabilis |
| |
Ceftazidime (all clinical specimens) |
| |
Ciprofloxacin (all clinical specimens) |
| |
Cefepime (all clinical specimens) |
| |
Cefoxitine (all clinical specimens) |
| |
Tobramycin (all clinical specimens) |
| |
Piperacillin/Tazobactam (all clinical specimens) |
| |
Multiresistance (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| Enterococcus spp |
| |
Gentamicin (all clinical specimens) |
| |
Streptomycin (all clinical specimens) |
| |
Vancomycin (all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| E. coli |
| |
Nalidixic acid (all clinical specimens) |
| |
Ciprofloxacin (all clinical specimens) |
|
Piperacillin/Tazobactam
(all clinical specimens) |
|
Ceftazidime
(all clinical specimens) |
|
Cefoxitine
(all clinical specimens) |
| |
Blood isolates (results from all hospitals) |
| |
Out patients (isolates from urine cultures) |
|
BACTERIAL SPECIES BY HOSPITAL |
| Blood cultures |
| |
Analysis by isolated species and type of ward |
